Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vilja

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
Human Pathology|April 16, 2025
Significance of mucin-suspended tumor bud-like structures in colorectal cancerVille K Äijälä, Päivi Sirniö, Hanna Elomaa, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancerPäivi Sirniö, Hanna Elomaa, Anne Tuomisto, et al.
Oncoimmunology|October 1, 2024
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenovirusesMichaela Feodoroff, Firas Hamdan, Gabriella Antignani, et al.
British Journal of Cancer|February 18, 2025
Associations of mucinous differentiation and mucin expression with immune cell infiltration and prognosis in colorectal adenocarcinomaHanna Elomaa, Vilma Tarkiainen, Ville K Äijälä, et al.
Oncoimmunology|July 29, 2025
Characteristics and significance of γδ T cells in colorectal cancerHenna Karjalainen, Jouni Härkönen, Päivi Sirniö, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Multimarker Assessment of B-Cell and Plasma Cell Subsets and Their Prognostic Role in the Colorectal Cancer MicroenvironmentOnni Sirkiä, Henna Karjalainen, Hanna Elomaa, et al.
Virchows Archiv : an International Journal of Pathology|March 6, 2026
Distance-based evaluation of tumor budding in colorectal cancerVille K Äijälä, Päivi Sirniö, Henna Karjalainen, et al.
British Journal of Cancer|December 11, 2025
Urothelium marker UPK2 identifies aggressive colorectal cancers with distinct molecular and histological featuresVille K Äijälä, Jouni Härkönen, Päivi Sirniö, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2025
Unraveling the effects and characteristics of proliferating tumor and cytotoxic T cells in colorectal cancerMeeri Kastinen, Jouni Härkönen, Päivi Sirniö, et al.
British Journal of Cancer|March 7, 2025
Stroma AReactive Invasion Front Areas (SARIFA), tumour immune microenvironment, and survival in colorectal cancerVilja V Tapiainen, Päivi Sirniö, Hanna Elomaa, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Human Pathology|April 16, 2025
Significance of mucin-suspended tumor bud-like structures in colorectal cancerVille K Äijälä, Päivi Sirniö, Hanna Elomaa, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancerPäivi Sirniö, Hanna Elomaa, Anne Tuomisto, et al.
Oncoimmunology|October 1, 2024
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenovirusesMichaela Feodoroff, Firas Hamdan, Gabriella Antignani, et al.
British Journal of Cancer|February 18, 2025
Associations of mucinous differentiation and mucin expression with immune cell infiltration and prognosis in colorectal adenocarcinomaHanna Elomaa, Vilma Tarkiainen, Ville K Äijälä, et al.
Oncoimmunology|July 29, 2025
Characteristics and significance of γδ T cells in colorectal cancerHenna Karjalainen, Jouni Härkönen, Päivi Sirniö, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Multimarker Assessment of B-Cell and Plasma Cell Subsets and Their Prognostic Role in the Colorectal Cancer MicroenvironmentOnni Sirkiä, Henna Karjalainen, Hanna Elomaa, et al.
Virchows Archiv : an International Journal of Pathology|March 6, 2026
Distance-based evaluation of tumor budding in colorectal cancerVille K Äijälä, Päivi Sirniö, Henna Karjalainen, et al.
British Journal of Cancer|December 11, 2025
Urothelium marker UPK2 identifies aggressive colorectal cancers with distinct molecular and histological featuresVille K Äijälä, Jouni Härkönen, Päivi Sirniö, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2025
Unraveling the effects and characteristics of proliferating tumor and cytotoxic T cells in colorectal cancerMeeri Kastinen, Jouni Härkönen, Päivi Sirniö, et al.
British Journal of Cancer|March 7, 2025
Stroma AReactive Invasion Front Areas (SARIFA), tumour immune microenvironment, and survival in colorectal cancerVilja V Tapiainen, Päivi Sirniö, Hanna Elomaa, et al.
Pageof 20